biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	63734D80-6D1D-4FBE-9101-833CF2CCD4A7
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AADV-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AADV-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AADV-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788102
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-DD-AADV.750CC634-8874-488C-B20D-6B636978156A.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A39J
biospecimen__bio__plate_row	C
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AADV
biospecimen__shared__patient_id	AADV
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	473A97D1-D855-48E1-9903-D569A4C9D695
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	3.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.8
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	11
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	50
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AADV-F68407
clinical__clin_shared__bcr_followup_uuid	1D492F56-6F7D-406E-AF09-5353D078459C
clinical__clin_shared__day_of_form_completion	17
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	187
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	Yes
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	01836749-15ed-4a64-a853-a77e07b323cf
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AADV-01A-11R-A39J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	6a5a3360-27b2-40f9-a233-1669e1792c37
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	c8ace561-2a3a-4823-9a2a-448574d246e3
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	4c78b999-4797-4e19-8bc5-9ffd01cf768a
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	778d7ca6-3919-59bc-a86d-399fbb8aab2d
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1963
gdc__diagnoses__age_at_diagnosis	18300
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-18300.0
gdc__diagnoses__days_to_last_follow_up	574.0
gdc__diagnoses__diagnosis_id	7f1e65cb-1149-52fd-b821-1412fb47eea3
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	20.661157024793386
gdc__exposures__exposure_id	af21765a-081c-52ef-82ce-962b48e22ff2
gdc__exposures__height	176.0
gdc__exposures__weight	64.0
gdc__file_id	d5dd15a2-cbe6-4ba7-9a4c-5336fb8db491
gdc__file_name	d83e165f-72b3-4b6e-b18b-881bfff3589a.mirbase21.mirnas.quantification.txt
gdc__file_size	50400
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	d2d2bb15789622298f543a1ca143b30a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6d59e2b8-3274-4727-8eb0-7ab2135a53e5
gdc__portions__portion_number	11
gdc__portions__weight	20.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	286
gdc__samples__initial_weight	20.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	750CC634-8874-488C-B20D-6B636978156A
gdc__samples__sample_id	bbe36805-117d-4923-92de-64b83dd318f0
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	75.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	4e1b3d63-fb32-4dec-8d52-3c9117addaf4
gdc__submitter_id	mirna_swap_dr11_87_MirnaExpression3cf32cea-faba-42d2-98b7-5f7ac46f5d62_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	10246dd2-3101-5b91-b5cb-92bf89f1ba6f
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:06:47.318+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/01836749-15ed-4a64-a853-a77e07b323cf-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/01836749-15ed-4a64-a853-a77e07b323cf-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129771
manually_curated__local_md5	353049b6efd60a35c898d2da03fe9036
manually_curated__opengdc_download_date	2018-10-16T17:12:08.000076+02:00
manually_curated__opengdc_file_md5	f17178514a78df6d6c8797ce183057c0
manually_curated__opengdc_file_size	50399
manually_curated__opengdc_id	01836749-15ed-4a64-a853-a77e07b323cf-meq
manually_curated__origin_file_size	129771
manually_curated__origin_last_modified_date	Tue Oct 16 18:08:00 CEST 2018
manually_curated__origin_md5	353049b6efd60a35c898d2da03fe9036
manually_curated__tissue_status	tumoral
